|
Dear Members,
The Board of Directors of Anjani Synthetics Limited (The
Company or Anjani) have great pleasure in presenting the (41st)
Forty-first Annual Report together with the Audited Financial Statements of the Company
for the financial year ended on 31st March 2025 (financial year under
review or financial year 2024-25).
FINANCIAL SUMMARY
The summary of the company's financial performance of the Company
during the financial year 2024-25 as compared to the previous financial year 2023-24 is
summarized below:
[Rupees in Lacs]
Particulars |
Financial Year 2023-2024 |
Financial Year 2024-2025 |
Revenue from operations |
22426.08 |
25423.77 |
Other income |
42.27 |
253.17 |
Total Revenue |
22468.35 |
25676.94 |
Expenses |
|
|
(a) Cost of materials consumed |
14717.12 |
18467.58 |
(b) Changes in inventories of FG, WIP
& Stock-in-Trade |
799.03 |
48.18 |
(c) Employee benefits expense |
620.81 |
557.23 |
(d) Finance costs |
294.16 |
464.94 |
(e) Depreciation and amortization expense |
239.18 |
254.59 |
(f) Other expenses |
5350.24 |
5507.01 |
Total Expenses |
22020.54 |
25203.17 |
Profit/ (Loss) before tax |
447.81 |
473.77 |
Tax expense: |
|
|
(a) Current tax expense |
117.15 |
68.08 |
(b) Deferred tax |
1.39 |
12.04 |
(c) Excess Provision of Tax for earlier
Years |
0.01 |
7.94 |
Profit / (Loss) for the year |
332.06 |
425.68 |
Earnings per share (face value Rs.10/-)
Basic & Diluted |
2.25 |
2.89 |
OPERATIONS REVIEW
The Company's revenue from operations during the financial year
ended 31st March 2025 was Rs. 22426.08 Lacs as against Rs. 25423.77 Lacs of the
previous year with total expenses of Rs. 22020.54 lacs (previous year of Rs. 25203.17
lacs). The Company has made Net Profit of Rs. 332.06 Lacs as against Rs.425.68 Lacs of the
previous year after considering Depreciation and Provision for Tax.
The EPS of the Company for the year 2024-25 is Rs. 2.25.
DIVIDEND
No dividend has been recommended in respect of the financial year ended
31st March 2025 and the entire surplus be ploughed back into the business to give
accelerator to the business of the company and generate higher profit in future.
SUBSIDIARY, JOINT VENTURE (JV) AND ASSOCIATES COMPANIES
During the year under review, the Company does not have any Subsidiary,
Joint Venture (JV) or Associates Company.
THE NAMES OF COMPANIES WHICH HAVE BECOME OR CEASED TO BE ITS
SUBSIDIARIES, JOINT VENTURES OR ASSOCIATE COMPANIES DURING THE YEAR
The names of companies which have become or ceased to be its
Subsidiaries, Joint Ventures or Associate companies during the year is not applicable
during the financial year 2024-25.
PUBLIC DEPOSIT
During the year under review, the Company has not accepted any deposits
from the public falling within the meaning of the provisions of Chapter V Acceptance of
Deposits under Companies Act, 2013 read with the Companies (Acceptance of Deposits) Rules,
2014.
THE DETAILS OF DEPOSITS WHICH ARE NOT IN COMPLIANCE WITH THE
REQUIREMENTS OF CHAPTER V OF THE ACT
During the year under review, the Company has not accepted any deposits
from the public falling within the meaning of the provisions of Chapter V Acceptance of
Deposits under Companies Act, 2013 read with the Companies (Acceptance of Deposits) Rules,
2014. So, the details of deposits which are not in compliance with the requirements of
Chapter V of the act is not applicable to the company.
LOAN FROM DIRECTORS:
The Company has not raised any loan from Directors during the financial
year 2024-25.
SHARE CAPITAL & LISTING
During the year under review there is no change in Authorized Share
Capital of the Company. The Authorized Share Capital of the Company as at 31st
March, 2025 stood at Rs. 15,00,00,000/- (Rupees Fifteen Crore) divided into 1,50,00,000
(One Crore Fifty Lakhs) equity shares of Rs. 10/- (Rupees Ten) each. Theissued, subscribed
and paid up Share capital of the company as at 31st March, 2025 stood at Rs.
14,75,00,000/- (Rupees Fourteen Crore Seventy Five Lakhs) divided into 1,47,50,000 (One
Crore Forty Seven Lakhs Fifty Thousand ) Equity Shares of Rs. 10/ - (Rupees Ten ) each. a)
The Company does not have any equity shares with differential rights; b) During the year
under report, the Company has not issued any sweat equity shares; c) During the year under
report, the Company has not issued any ESOP; d) Provision of money by Company for purchase
of its own shares by employees or by trustees for the benefit of employees: The Company
has not made any provision of money for the purchase of, or subscription for, shares in
the Company, to be held by or for the benefit of the employees of the Company and hence
the disclosure as required under Rule 16(4) of the Companies (Share Capital and
Debentures) Rules, 2014 is not required.
e) Listing with the stock exchanges: The Company's equity shares
are listed on the Bombay Stock Exchange Limited (BSE) and it has paid the Annual Listing
Fees for the financial year 2024-25. f) Disclosure with respect to shares transferred in
IEPF Account: In terms of the provisions of Investor Education and Protection Fund
(Accounting, Audit, Transfer and Refund) Rules, 2016, 7,282 shares whose dividends were
unpaid/unclaimed for seven consecutive years taking the base year as Interim dividend for
the FY 2007-08 were transferred during the year to the Investor Education and Protection
Fund.
TRANSFER TO RESERVE
The amount of net profit of Rs. 332.06 Lacs (previous year Rs. 425.68
Lacs) is proposed to be held as Retained Earnings. Details of reserve and surplus are
provided in Note No. 14 of the Financial Statement for the Financial Year 2024-25.
CHANGE IN NATURE OF BUSINESS
During the period under review, there is no change in the nature of
business.
DIRECTORS AND KEY MANAGERIAL PERSONNEL
The Board of Directors of the company has various Executive and
Non-Executive Directors including Independent Directors who have wide experience in
different disciplines of corporate functioning. The details of the Directors during the
year has prescribed in the Corporate Governance Report.
During the Financial Year 2024-25, Mr. Alpesh Fatehsingh Purohit (DIN:
07389212) Independent Director of the company has tender his resignation w.e.f. 13th August,
2024 and Ms. Ishali Desai (DIN: 10738484) has appointed as Independent Director of the
company w.e.f. 13th August, 2024.
All Independent Directors have given declarations that they meet the
criteria of Independence as laid down under Section 149(6) of the Companies Act, 2013 and
Regulation 25 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015. The terms and conditions of the Independent Directors are incorporated on the
website of the Company www.anjanisynthetics.com.
Key Managerial Personnel
As on March 31, 2025, the following persons have been designated as Key
Managerial Personnel (KMP) of the Company pursuant to the provisions of
Sections 2(51) and 203 of the Act read with the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014:
Sr. No. |
Name of Director/KMP |
PAN/DIN |
Designation |
1 |
Vasudev Subhkaran Agarwal |
1491403 |
Managing Director |
2 |
Sandeep Mehta |
AWJPM1953H |
CFO |
3 |
Vikas Anandi Sharma |
BMPPS5063K |
CEO |
4 |
Anjali Barot * |
CAPPV4719N |
Company Secretary |
5 |
J aydeepDahyabhaiPrajapati ** |
GSSPP1031C |
Company Secretary |
* Mrs. Anjali Barot resigned from the post of Company Secretary w.e.f.
31st May 2025.
** Mr. JaydeepDahyabhaiPrajapati has been appointed as the Company
Secretary & Compliance officer w.e.f. 1st June 2025.
The Company has compiled with the requirements of having Key Managerial
Personnel as per provisions of Section 203 of the Companies Act, 2013.
DISCLOSURE RELATED TO BOARD AND COMMITTEES
a) Number of Board Meetings conducted during the year under review
Regular Board Meetings are held once in a quarter, inter-alia, to
review the quarterly results of the Company.
During the year under review 9 (NINE) Board Meetings were held. The
intervening gap between the two meetings was within the period prescribed under the
Companies Act, 2013. The details of the meetings are furnished in the Corporate Governance
Report which forming part of this Annual Report.
b) Independent Directors' Meeting
The Independent Directors met on the 28th August 2024,
without the attendance of Non-Independent Directors and members of the Management. The
Independent Directors reviewed the performance of Non-Independent Directors and the Board
as a whole; the performance of the Chairperson of the Company, taking into account the
views of Executive Directors and Non-Executive Directors and assessed the quality,
quantity and timeliness of flow of information between the Company Management and the
Board that is necessary for the Board to effectively and reasonably perform their duties.
c) Committees of the Board of Directors
Your Company has several Committees which have been established as part
of the best Corporate Governance practices and are in compliance with the requirements of
the relevant provisions of applicable laws and statutes.
The Company has following Committees of the Board of Directors: *Audit
Committee *Stakeholder Relationship Committee *Nomination and Remuneration Committee
The details with respect to the compositions, powers, and terms of
reference and other information of relevant committees are given in details in the
Corporate Governance Report which forms part of this Annual Report.
d) Board Evaluation:
Pursuant to the corporate governance requirements as prescribed in the
Companies Act, 2013 and the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements), Regulations 2015, the Board of Directors has carried out an
annual evaluation of its own performance, Board Committees and of individual directors. In
a separate meeting of independent directors, performance of non-independent directors,
performance of the Board as a whole, performance of the Committee(s) of the Board and
performance of the Chairman was evaluated, taking into account the views of other
directors. Performance evaluation of independent directors was done by the entire Board,
excluding the independent director being evaluated.
e) Board Diversity:
The Board of Directors of the company has various Executive,
Non-Executive Directors, Independent Directors and Women Independent Director(s) who have
wide experience in different disciplines of corporate functioning.
VARIOUS COMPANIES' POLICIES
In accordance with the provisions of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 and the Companies Act, 2013 the Company has
formulated and implemented the various policies. All the Policies are available on
Company's website (www.anjanisynthetics.com ) under the heading Investor
Relations. The policies are reviewed periodically by the Board
and updated based on need and requirements.
a) Policy on Director's Appointment and Remuneration
The Company has a Nomination and Remuneration Committee. The Committee
reviews and recommend to the Board of Directors about remuneration for Directors and Key
Managerial Personnel and other employee up to one level below of Key Managerial Personnel.
The Company does not pay any remuneration to the Non-Executive Directors of the Company
other than sitting fee for attending the Meetings of the Board of Directors and Committees
of the Board. Remuneration to Executive Directors is governed under the relevant
provisions of the Act and approvals.
The Company has devised the Nomination and Remuneration Policy for the
appointment, reappointment and remuneration of Directors, Key Managerial Personnel. All
the appointment, reappointment and remuneration of Directors and Key Managerial Personnel
are as per the Nomination and Remuneration Policy of the Company.
b) Vigil Mechanism
The Company has established a vigil mechanism and accordingly framed a
Whistle Blower Policy. The policy enables the employees to report to the management
instances of unethical behavior, actual or suspected fraud or violation of Company's
Code of Conduct. Further the mechanism adopted by the Company encourages the Whistle
Blower to report genuine concerns or grievances and provide for adequate safe guards
against victimization of Whistle Blower who avails of such mechanism and also provides for
direct access to the Chairman of the Audit Committee, in exceptional cases. The
functioning of vigil mechanism is reviewed by the Audit Committee from time to time. None
of the Whistle blowers has been denied access to the Audit Committee of the Board.
c) Risk Management Policy
The Company is aware of the risks associated with the business. It
regularly analyses and takes corrective actions for managing/ mitigating the same. The
Company has framed a formal Risk Management Framework for risk assessment and risk
minimization which is periodically reviewed to ensure smooth operation and effective
management control. The Audit Committee also reviews the adequacy of the risk management
framework of the Company, the key risks associated with the business and measure and steps
in place to minimize the same.
d) Related Party Transactions Policy
The policy on Related Party Transactions as approved by the Board of
Directors is uploaded on the website of the Company as per provisions of Regulation 23 of
the SEBI (LODR) Regulations, 2015 and other applicable provisions of the Companies Act,
2013.
e) Dividend Distribution Policy
Pursuant to Regulation 43A of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, the top thousand listed entities based on
market capitalization are required to formulate the Dividend Distribution Policy.
Accordingly, your Company is not required to formulate the Dividend Distribution Policy.
CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES
All related party transactions entered into during the financial year
were on an arm's length basis and were in the ordinary course of business. The
Company entered into transactions with related parties in terms of Section 188 of the
Companies Act, 2013. Therefore, the disclosure of related party transactions as required
under Section 134(3)(h) of the Companies Act, 2013 in Form AOC 2 is annexed as Annexure I.
Suitable disclosure as required by the Indian Accounting Standard (Ind AS 24) has been
made in the notes to the Financial Statements.
All Related Party transactions are placed before the Audit Committee
for approval, wherever applicable. Prior omnibus approval for normal business transactions
is also obtained from the Audit Committee for the related party transactions which are of
repetitive nature and accordingly the required disclosures are made to the Committee on
quarterly basis in terms of the approval of the Committee. The details of Related Party
Transactions are given in the notes to the financial statements.
COST RECORDS
Pursuant to Rule 8 of the Companies (Accounts) Rules, 2014 read with
Section 134 your Company has duly maintained the cost records as per sub-section 1 of
section 148 of Companies Act, 2013.
AUDITORS & AUDITOR'S REPORT
a) Statutory Auditors:
The Members of the Company at its Thirty-Eight (38th) Annual General
Meeting held on 28th September 2022 has approved the appointment of M/s. Nahta Jain &
Associates, Chartered Accountants, Ahmedabad (Firm Registration No. 106801W) as the
Statutory Auditors of the Company, for a period of five (5) years to hold the office of
the Statutory Auditors of the Company from the conclusion of 38th Annual General Meeting
till the conclusion of 43rd Annual General Meeting of the Company in place of M/s.
Abhishek Kumar & Associates, Chartered Accountants (Firm's Registration No.
130052W) retiring statutory auditor.
The notes on financial statements referred to in the Auditors'
Report are self-explanatory and do not required any further comments.
The report does not contain any qualification, reservation or adverse
remark.
b) Internal Auditors:
M/s. ACM & Associates, Chartered Accountants, Ahmedabad has been
appointed as Internal Auditors of the Company for FY 2024-25. Internal Auditors are
appointed by the Board of Directors of the Company on a yearly basis, based on the
recommendation of the Audit Committee. The Internal Auditor reports their findings on the
Internal Audit of the Company, to the Audit Committee on a yearly basis. The scope of
internal audit is approved by the Audit Committee.
c) Cost Auditors:
The Company has appointed M/s. Kiran J. Mehta & Co., Cost
Accountants, Ahmedabad as Cost Auditor of the Company to audit the cost accounts for the
financial year 2024-25.
As per Section 148 read with Companies (Audit & Auditors) Rules,
2014 and other applicable provisions, if any, of the Companies Act, 2013 the Board of
Directors has appointed M/s. Kiran J. Mehta & Co., Cost Accountants as the Cost
Auditor of the Company for the financial year 2024-25 on the recommendations made by the
Audit Committee subject to the approval of the Central Government.
d) Secretarial Auditors:
Pursuant to the provisions of Section 204 of the Companies Act, 2013
and The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, your
Company had re-appointed M/s Mukesh H. Shah & Co, Practicing Company Secretaries of
Ahmedabad to undertake the Secretarial Audit of the Company for the Financial Year
2024-25. The secretarial audit report for the financial year 2024-25 is annexed to this
Annual Report as Annexure-II.
Reply to Observation of Secretarial Auditor:
As per Investor Education and Protection Fund Authority (Accounting,
Audit, Transfer and Refund) Second Amendment Rules, 2019, Company was required to file
form IEPF-4 regarding statement of shares to be transferred to the Investor Education and
Protection Fund for the interim dividend paid in financial year 2008-09 but the Company is
unable to file form IEPF-4 due to some technical issues in the form. The company is
continuously trying to resolve the technical issues in form IEPF-4.
DETAILS IN RESPECT OF FRAUDS REPORTED BY AUDITORS OTHER THAN THOSE
WHICH ARE REPORTABLE TO THE CENTRAL GOVERNMENT
The Statutory Auditors of the Company have not reported any fraud to
the Audit Committee or to the Board of Directors under Section 143(12) of the Companies
Act, 2013 read with Rule 13 of the Companies (Audit and Auditors) Rules, 2014.
ANNUAL RETURN
Pursuant to Section 92(3) read with Section 134(3) (a) of the Act as
amended, the Annual Return is available on the Company's website
www.anjanisynthetics.com.
CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION & FOREIGN EXCHANGE
EARNINGS AND OUTGO
Information relating to Conservation of Energy, Technology Absorption
and Foreign Exchange Earning and Outgo, required under Section 134 (3) (m) of the
Companies Act, 2013 forms part of this Annual Report as Annexure-III.
CORPORATE GOVERNANCE REPORT
The Company has taken adequate steps to adhere to all the stipulations
laid down under Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015. A report on Corporate Governance included as a part of
this Annual Report is given in Annexure-IV.
A certificate from the Secretarial Auditors of the company confirming
the compliance with the conditions of Corporate Governance as stipulated under Reg. 27
& 34 the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 is attached to this Annual Report.
CORPORATE GOVERNANCE & MANAGEMENT DISCUSSION & ANALYSIS REPORT
Your Company is in compliance with all the applicable provisions of
Corporate Governance as stipulated under Chapter IV of the Listing Regulations. A detailed
report on Corporate Governance as required under the Listing Regulations is provided in a
separate section and forms part of the Annual Report. Certificate from the Practicing
Company Secretary regarding compliance with the conditions stipulated in the Listing
Regulations forms part of the Corporate Governance Report.
The Management Discussion and Analysis Report as required under the
Listing Regulations are presented in a separate section and forms part of the Annual
Report as Annexure V.
INSURANCE
Assets of your Company are adequately insured against various perils.
MATERIAL CHANGES AND COMMITMENT AFFECTING FINANCIAL POSITION OF THE
COMPANY
There are no material changes and commitments affecting the financial
position of the Company which has occurred between the end of financial year as on 31st
March 2025 and the date of Director's Report i.e. 29th August, 2025.
PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS
The details of Loans, Guarantees or Investments covered under the
provisions of section 186 of the Companies Act, 2013 made during the year under review are
disclosed in the financial statements.
PARTICULARS OF EMPLOYEES
Details pertaining to remuneration as required under section 197(12) of
the companies act, 2013 read with rule 5(1) of the companies (appointment and remuneration
of managerial personnel) rules, 2014:
a) The percentage increase in remuneration of each Director, Chief
Executive officer, Chief Financial Officer and Company Secretary during the financial year
2024-25 and ratio of the remuneration of each Director to the median remuneration of the
employees of the Company for the financial year 2024-25 are as under:
Remuneration Ratio of Directors/ KMP/ Employees:
Name & Designation |
Remuneration
Paid |
+/- in remuneration from
previous year (Rs.) |
Ratio/ Times per Median of
employee remuneration |
|
FY 2024-25 |
FY 2023-24 |
|
|
|
(Rs in lacs) |
(Rs in lacs) |
|
|
Vasudev S. Agarwal Chairman
& MD |
24,00,000 |
24,00,000 |
0 |
4.7553 |
Sanjay Goverdhan Sharma
Executive Director |
7,25,000 |
6,70,110 |
54,890 |
1.4365 |
Manoharlal I Sharma Chief
Financial Officer (upto 14.08.2023) |
0 |
57,980 |
57,980 |
0 |
Sandeep Mehta Chief
Financial Officer (W.e.f. 14.08.2023) |
7,75,300 |
7,38,030 |
37,270 |
1.5361 |
Vikas Sharma Chief
Executive Officer |
6,97,600 |
7,45,140 |
47,540 |
1.3822 |
NikiPatawari Company
Secretary (upto 27.03.2024) |
0 |
3,60,000 |
3,60,000 |
0 |
Anjali Barot Company
Secretary (W.e.f. 30.05.2024) |
3,15,964 |
- |
3,15,964 |
0.626 |
Note: Except Key Managerial Personnel i.e. Managing Director, Chief
Financial officer, Chief Executive officer and Company Secretary, no other directors
received any remuneration from the Company other than sitting fees for attending Board
meetings and Committees meetings.
b) Median remuneration of employees was Rs. 5.04/- during the year
2024-25.
c) The particulars of the employees who are covered by the provisions
contained in Rule 5(2) and rule 5(3) of Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014 are as follows:
The number of permanent employees on the Payroll of Company: 107 (One
hundred and seven) as on 31 March 2025.
d) It is hereby affirmed that the remuneration paid is as per the c and
Remuneration Policy for Directors, Key Managerial Personnel and other Employees.
INTERNAL FINANCIAL CONTROL SYSTEMS AND THEIR ADEQUACY
The Company has adequate internal control system, which is commensurate
with the size, scale and complexity of its operations. The Company has a process in place
to continuously monitor existing controls and identify gaps and implement new and / or
improved controls wherever the effect of such gaps would have a material impact on the
Company's operation.
Further, the Internal Auditor monitors and evaluates the efficacy and
adequacy of internal control system in the Company, its compliance with the operating
systems, accounting procedures and policies of the Company. Based on the report of
Internal Auditor, the process owners undertake the corrective action in their respective
areas and thereby strengthen the Control. Significant audit observation and corrective
actions thereon are presented to the Audit Committee of the Board.
DIRECTORS' RESPONSIBILITY STATEMENT
As stipulated in Section 134(3)(c) read with sub section 5 of the
Companies Act, 2013, Directors subscribe to the Directors' Responsibility
Statement, and confirm that:
a) In preparation of annual accounts for the year ended 31st
March 2025, the applicable accounting standards have been followed and that no material
departures have been made from the same;
b) The Directors had selected such accounting policies and applied them
consistently and made judgments and estimates that are reasonable and prudent so as to
give a true and fair view of the state of affairs of the Company at the end of the
financial year and of the profit or loss of the Company for that year;
c) The Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the provisions of the
Companies Act, 2013, for safeguarding the assets of the Company and for preventing and
detecting fraud and other irregularities;
d) The Directors had prepared the annual accounts for the year ended 31st
March 2025 on going concern basis.
e) The Directors had laid down the internal financial controls to be
followed by the Company and that such Internal Financial Controls are adequate and were
operating effectively; and
f) The Directors had devised proper systems to ensure compliance with
the provisions of all applicable laws and that such systems were adequate and operating
effectively.
DECLARATION OF INDEPENDENT DIRECTORS
The Company has received a declaration from the Independent Directors
that they meet the criteria of independence as per section 149 of the companies Act, 2013.
CORPORATE SOCIAL RESPONSIBILITY
During the financial year under review, the provisions of Section 135
of the Act relating to the Corporate Social Responsibility are not applicable to your
Company.
COMPLIANCE WITH SECRETARIAL STANDARDS
Your Company has complied with Secretarial Standards issued by the
Institute of Company Secretaries of India on Board and General Meetings.
SIGNIFICANT OR MATERIAL ORDERS WERE PASSED BY THE REGULATORS OR COURTS
OR TRIBUNALS WHICH IMPACT THE GOING CONCERN STATUS AND COMPANY'S OPERATIONS IN
FUTURE.
During the year under review, No significant or material orders were
passed by the Regulators or Courts or Tribunals which impact the going concern status and
Company's operations in future.
THE DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER THE
INSOLVENCY AND BANKRUPTCY CODE, 2016 (31 OF 2016) DURING THE YEAR ALONG WITH THEIR STATUS
AS AT THE END OF THE FINANCIAL YEAR.
No application made, or any proceeding is pending under the Insolvency
and Bankruptcy Code, 2016, during the financial year 2024-25.
THE DETAILS OF DIFFERENCE BETWEEN AMOUNT OF THE VALUATION DONE AT THE
TIME OF ONE TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING LOAN FROM THE BANKS OR
FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF.
There are no changes in the Valuation done for One Time Settlement and
Loan from the Banks or Financial Institutions during the financial year 2024-25.
COMPLIANCE WITH THE PROVISIONS OF SEXUAL HARASSMENT OF WOMEN AT WORK
PLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013
The Company has zero tolerance for sexual harassment at workplace and
has adopted a policy on prevention, prohibition and redressal of sexual harassment at
workplace in line with the provisions of Sexual Harassment of Women at Workplace
(Prevention, Prohibition and Redressal) Act, 2013 and the rules framed thereunder. During
the financial year 2024-25, the Company has not received any complaints on sexual
harassment.
CAUTIONARY NOTE
The statement in the Directors Report and the Management Discussion and
Analysis Report describing the Company's objectives, expectations or predictions, may
be forward looking within the meaning of applicable securities laws and regulations.
Actual results may differ materially from those expressed in the statement. These risks
and uncertainties include the effect of economic and political conditions in India,
volatility in interest rates, new regulations and Government policies that may impact the
Company's business as well as its ability to implement the strategy. The Company does
not undertake to update these statements.
ACKNOWLEDGEMENT
Your directors would like to express their appreciation for the
assistance and co-operation received from the financial institutions, banks, Government
authorities, customers, vendors and members during the year under review your Directors
place on record their deep appreciation to employees at all levels and workers for their
hard work, dedication and commitment.
|
For and on behalf of the Board of
Directors |
|
For, ANJANI SYNTHETICS LIMITED |
Place : Ahmedabad |
|
Date : 29th August, 2025 |
Sd/- |
|
VASUDEV S. AGARWAL |
|
(DIN: 01491403) |
|
CHAIRMAN & MD |
|